• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The evolution of technology in clinical trial conduct

The evolution of technology in clinical trial conduct

June 15, 2016
CenterWatch Staff

The vaccine industry has trans­formed so completely it has become almost unrecognizable from the disease prevention model originally envisioned over 100 years ago.

Thanks to the tireless efforts of such giants as Jenner, Pasteur, Salk, Sabin and more recently or­ganizations such as GAVI and The Global Fund, disease prevention sits as one of the cornerstones of global public health. Today, vac­cine research has expanded be­yond vaccines focused solely on disease prevention and now in­cludes therapeutic vaccines, DNA vaccines and recombinant vac­cines.

Immuno-therapeutic vaccines are rapidly becoming some of the hottest areas of research in mod­ern medicine and are being inves­tigated by large pharma and small-to-medium biotechs alike. But have clinical trial methods evolved to keep pace? On the surface the answer seems to be yes.

Paper CRFs and diaries, tele­phone call-back systems and armies of CRAs reviewing paper sources have given way to elec­tronic data capture (EDC) sys­tems, Interactive Voice Response Systems (IVRS), remote site moni­toring and CDISC standards. But is this enough?

Historically, new technologies are added to study protocols as af­terthoughts, but until the industry commits to standards and insists on interoperability, we won’t be able to fully realize the potential of their use and benefit from the efficiencies. It is critical that as an industry, we carefully consider the appropriate use of these technolo­gies and work together to support and adopt standards to ensure that the systems selected can work to­gether seamlessly. In doing so, study conduct can keep pace with the ever more demanding trial design necessary to support these modern wonder vaccines and pos­sibly the eventual evolution of tai­lored vaccines.

 

Written by Guest Writer Darin Seehafer. Seehafer has over 20 years of clinical research experience working in all FDA phases of study design from preclinical benchtop studies through post-licensure. Currently a clinical scientist with PRA, he continues to provide input on trial design and study oversight, liaising with key opinion leaders and serving as a subject matter expert for clients on all things vaccines. He also continues his work as a vaccine advocate and author. Visit www.prahs.com.

This article was reprinted from Volume 23, Issue 05, of The CenterWatch Monthly, an industry leading publication providing hard-hitting, authoritative business and financial coverage of the clinical research space. The Action Items section features short columns  focusing on actionable or how-to advice from clinical trial professionals. To submit an Action Item, please contact editorial@centerwatch.com. Subscribe >>

Upcoming Events

  • 17May

    Three Data Trends to Consider Now When Developing Your Decentralized Clinical Trial Strategy

  • 24May

    Powering an Effective Oversight Strategy with Clinical and Operational Insights

  • 25May

    2022 WCG Avoca Quality & Innovation Summit: Own the Future

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing